CDKN1B and melanoma: Two-thirds of OMMs contain p53 protein changes, and a recent study found that loss of heterozygosity at 12p13 and loss of p27KIP1 protein expression [7] contribute to melanoma progression; whereas less than 10% of cases showed BRAF mutation [8].